A polygenic score associated with fracture risk in breast cancer patients treated with aromatase inhibitors
Abstract Identifying women at high risk of osteoporotic fracture from aromatase inhibitor (AI) therapy for breast cancer is largely based on known risk factors for healthy postmenopausal women, which might not accurately reflect the risk in breast cancer patients post-AI therapy. To determine whethe...
Main Authors: | Christine Hook, Udit Chatterjee, Haiyang Sheng, Qianqian Zhu, Timothy Robinson, Janise M. Roh, Cecile A. Laurent, Catherine Lee, Jennifer Delmerico, Joan C. Lo, Christine B. Ambrosone, Lawrence H. Kushi, Marilyn L. Kwan, Song Yao |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-01-01
|
Series: | npj Breast Cancer |
Online Access: | https://doi.org/10.1038/s41523-024-00615-9 |
Similar Items
-
Early‐onset triple‐negative breast cancer in multiracial/ethnic populations: Distinct trends of prevalence of truncation mutations
by: Qian Liu, et al.
Published: (2019-04-01) -
SeqSQC: A Bioconductor Package for Evaluating the Sample Quality of Next-generation Sequencing Data
by: Qian Liu, et al.
Published: (2019-04-01) -
Plant-Based Dietary Patterns and Breast Cancer Recurrence and Survival in the Pathways Study
by: Ijeamaka C. Anyene, et al.
Published: (2021-09-01) -
Development and testing of a polygenic risk score for breast cancer aggressiveness
by: Yiwey Shieh, et al.
Published: (2023-05-01) -
UACA locus is associated with breast cancer chemoresistance and survival
by: Qianqian Zhu, et al.
Published: (2022-03-01)